hydroxypropyl cellulose
Sponsors
Ospedale San Raffaele S.r.l., Recursion Pharmaceuticals Inc.
Conditions
Familial Adenomatous Polyposisnew-onset autoimmune type 1 diabetes
Phase 2
A phase 2b, single-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of oral Ladarixin in association with a single low dose of Antithymocyte Globulin in patients with new-onset autoimmune type 1 diabetes.
WithdrawnCTIS2025-524298-18-00
Target: 46Updated: 2026-04-09
A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of REC-4881 in Patients with Familial Adenomatous Polyposis (FAP)
Not yet recruitingCTIS2026-525282-50-00
Target: 15Updated: 2026-07-13